Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Diamond Peak’s CTA program continues 7-month winning streak, up 0.61% in June (+13.48% YTD)

Thursday, July 14, 2011

From Komfie Manalo, Opalesque Asia:

The "zig zag market character" of 2011 so far has helped Diamond Peak Capital’s CTA program, called the Diamond Peak Northstar Aggressive (2x) program, to maintain its seven-month winning streak since December 2010 and finish June up 0.61% and the first half of the year up 13.48%. Steven Sapourn, Portfolio Manager for the Northstar program told Opalesque that the program thrived during the past seven months despite a tough environment for CTAs.

Most CTA indices are down so far this year. For example, the Eurekahedge CTA / Managed Futures Hedge Fund Index was down 2.27% (est.) in June (and down 3% YTD).

Featured in Opalesque Solutions’ Emerging Managers Database, Northstar generated alpha from both its long and short core strategies, with its more uncorrelated systems helping to mitigate volatility. As Sapourn pointed out; "Markets that zig and zag rather than move in a straight line are the best environment for what we do."

This year started off with strong economic data with the S&P registering multi-year highs until mid-February. But the political turmoil in the Middle East and the disasters in Japan brought by the powerful earthquake and the eventual nuclear crisis halted the rally. Recently, the possible default in Greece sovereign debt issue has eroded market confidence a......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner